{"id":"NCT01721772","sponsor":"Bristol-Myers Squibb","briefTitle":"Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma","officialTitle":"A Phase 3, Randomized, Double-Blind Study of BMS-936558 vs Dacarbazine in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-01-18","primaryCompletion":"2014-06-24","completion":"2021-05-14","firstPosted":"2012-11-06","resultsPosted":"2016-02-25","lastUpdate":"2022-07-12"},"enrollment":418,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Melanoma"],"interventions":[{"type":"BIOLOGICAL","name":"BMS-936558 (Nivolumab)","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo matching BMS-936558 (Nivolumab)","otherNames":[]},{"type":"DRUG","name":"Dacarbazine","otherNames":[]},{"type":"DRUG","name":"Placebo matching Dacarbazine","otherNames":[]}],"arms":[{"label":"Nivolumab, 3 mg/kg","type":"EXPERIMENTAL"},{"label":"Dacarbazine, 1000 mg/m^2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the clinical benefit, as measured by overall survival, of nivolumab with that of. dacarbazine in patients with previously untreated, unresectable, or metastatic melanoma","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"From date of randomization to date of death. For those without documentation of death, to the last date the participant was known to be alive, assessed up to 17 months.","effectByArm":[{"arm":"Nivolumab, 3 mg/kg + Placebo-matching Dacarbazine","deltaMin":null,"sd":null},{"arm":"Dacarbazine, 1000 mg/m^2 + Placebo-matching Nivolumab","deltaMin":10.84,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":3},"locations":{"siteCount":75,"countries":["Argentina","Australia","Canada","Chile","Denmark","Finland","France","Germany","Greece","Israel","Italy","Mexico","Norway","Poland","Spain","Sweden"]},"refs":{"pmids":["39504507","32997575","30422243","30215677","28662232","25399552"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","https://www.BMSStudyConnect.com"]},"adverseEventsSummary":{"seriousAny":{"events":125,"n":206},"commonTop":["Nausea","Fatigue","Diarrhoea","Constipation","Pruritus"]}}